Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court on Tuesday for allegedly ...
Bayer has filed patent infringement lawsuits against COVID-19 vaccine makers Pfizer, BioNTech, Moderna, and Johnson & Johnson ...
Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS ...
Bayer has filed separate lawsuits against the creators of three COVID-19 vaccines, claiming they violated intellectual ...
Bayer's Monsanto has sued Pfizer, BioNTech and Moderna for allegedly misusing its messenger RNA technology in COVID vaccines.
Zacks Investment Research on MSN
MRNA stock jumps on global submissions seeking nod for flu vaccine
Moderna MRNA announced that it submitted regulatory filings seeking approval for its seasonal influenza vaccine mRNA-1010 ...
The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.
Moderna is working with advanced technology to help transform the way medicines are created, but is that enough reason to stick around? The main reason to buy Moderna is its use of mRNA technology to ...
(The Hill) — Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover ...
CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an update on regulatory submissions for its investigational seasonal influenza vaccine, mRNA-1010, for ...
Filed in a Delaware federal court, the lawsuits claim the companies copied technology developed by Bayer's subsidiary, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results